T609-0807 Screening compound: 4-[6-(1H-imidazol-1-yl)pyrimidin-4-yl]thiomorpholine

T609-0807 Screening compound: 4-[6-(1H-imidazol-1-yl)pyrimidin-4-yl]thiomorpholine
T609-0807 Screening compound: 4-[6-(1H-imidazol-1-yl)pyrimidin-4-yl]thiomorpholine alternative view

Chemical Structure Depiction of ChemDiv screening compound T609-0807
4-[6-(1H-imidazol-1-yl)pyrimidin-4-yl]thiomorpholine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T609-0807

Molecular Formula

C11H13N5S (C11 H13 N5 S)

Compound Name

4-[6-(1H-imidazol-1-yl)pyrimidin-4-yl]thiomorpholine

IUPAC name

4-[6-(1H-imidazol-1-yl)pyrimidin-4-yl]thiomorpholine

SMILES

C(CSCC1)N1c1ncnc(-n2cncc2)c1

InChI

InChI=1S/C11H13N5S/c1-2-16(9-12-1)11-7-10(13-8-14-11)15-3-5-17-6-4-15/h1-2,7-9H,3-6H2

InChI Key

XBYPFYLIOCRUSW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27622468

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

247.32

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

2.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

1.713

Distribution Coefficient, logD

1.631

Water Solubility, LogSw

-1.72

Polar Surface Area

35.153

Acid Dissociation Constant (pKa)

23.11

Base Dissociation Constant (pKb)

6.72

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

36.40

T609-0807 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Fragments Library (11262 compounds)

GPCR Targeted Library (31838 compounds)

SmartTM Library (51161 compounds)

Soluble Diversity Library (15920 compounds)

Targeted Diversity Library (40567 compounds)

Akt-Targeted Library (14764 compounds)

Ion Channels Focused Library (26372 compounds)

Included in 1.7M Stock Database

Structure:
  • Fragments
Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Nervous system
  • Cardiovascular
Targets:
  • GPCR
  • Kinases
  • Ion Channels
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with T609-0807 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T609-0807?
Check Price and Availability of T609-0807, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T609-0807 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T609-0807
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T609-0807
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T609-0807 available by request